Page last updated: 2024-09-05

lf 150195 and Multiple Sclerosis

lf 150195 has been researched along with Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beriou, G; Bruand, C; Cuturi, MC; Duplan, V; Dutartre, P; Heslan, JM; Liblau, RS; Mars, LT; Saoudi, A	1

Other Studies

1 other study(ies) available for lf 150195 and Multiple Sclerosis

Article	Year
LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells. Journal of immunology (Baltimore, Md. : 1950), 2006, Jan-15, Volume: 176, Issue:2 Topics: Adoptive Transfer; Animals; Base Sequence; CD4-Positive T-Lymphocytes; DNA; Encephalomyelitis, Autoimmune, Experimental; Forkhead Transcription Factors; Gene Expression; Guanidines; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Myelin Basic Protein; Neutralization Tests; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Chemokine; Transforming Growth Factor beta	2006

Article

Year

LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.

Journal of immunology (Baltimore, Md. : 1950), 2006, Jan-15, Volume: 176, Issue:2

Topics: Adoptive Transfer; Animals; Base Sequence; CD4-Positive T-Lymphocytes; DNA; Encephalomyelitis, Autoimmune, Experimental; Forkhead Transcription Factors; Gene Expression; Guanidines; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Myelin Basic Protein; Neutralization Tests; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Chemokine; Transforming Growth Factor beta

2006